---
$id: https://graph.org.ai/products/commodity/51171974
$type: Product
source: UNSPSC
code: "51171974"
title: "Imiglucerase"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Imiglucerase

**UNSPSC Code**: 51171974
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an enzyme replacement preparation with the molecular formula C2532H3843N671O711S16, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q6U6J48BWY, more generally known as imiglucerase. European Medicines Agency schedules imiglucerase in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08148MIG. The term IMIGLUCERASE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, no. 3, 1995, list 35. IMIGLUCERASE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule Imiglucerase under HS 35079090 and SITC 51691. SMILES:. As of Q4 2014, IMIGLUCERASE remains the US FDA Preferred Term for this commodity. . Imiglucerase bears US NLM identifiers UMLS ID C0291139 and NCI Concept Code C65896.

